Policy Reporter
Tim Ogren is an experienced professional with a robust background in product management and sales within the pharmaceutical industry. Currently serving as General Manager at Policy Reporter since October 2021, Tim previously held various senior leadership roles at TrialCard, including Chief Product Officer and Senior Vice President of Product Management. In these roles, Tim led the Product Management team to align corporate strategies with market needs, assisting pharmaceutical brands in enhancing patient and prescriber loyalty. Prior experience includes positions at Informatica, Channel Advisor Corporation, SAS, and DataDirect Technologies, showcasing a strong foundation in sales and account management. Tim holds a degree from the University of Missouri-Columbia and is a graduate of Bishop Miege.
This person is not in the org chart
Policy Reporter
Policy Reporter by Mercalis is an industry-leading service that provides business intelligence to the medical industry. Our objective is to improve the way the medical industry receives, processes, and acts on healthcare policy developments by providing access to the very latest payer coverage data. Policy Reporter leverages its proprietary software to track medical, diagnostic, and pharmaceutical policy updates as they happen, all across the United States. No other consultancy or company exclusively serves the market access industry the way we do. Our automated, real-time approach to tracking policy changes combined with the depth of our expertise provides our customers with an invaluable market access resource. Subscribers to Policy Reporter Can: • Receive live payer policy alerts. • Track medical policies, pharmacy policies, formularies, billing guidelines, and other key documents. • Access payer policy documents in a central database. • Analyze coverage for their product and competing products through dynamic reporting and analysis tools. • Research key payer data including payer contacts, covered lives, contractual relations, and more to optimize their market access strategy.